Group items tagged

The Global Non-Opioid Pain Relief Device Market, which was valued at US$ 5,031 million in 2022, is expected to reach US$ 10,311 million by 2031, signaling a significant growth trajectory at a CAGR 8.3% during the forecast period 2031-2031.

The Global Anthrax Vaccine Market is expected to grow at a steady CAGR of 6.7%, fueled by increasing bioterrorism threats and growing awareness about the disease. As of 2022, the market was valued at US$ 599 million and is expected to surpass a valuation of US$ 1,006.33 million by 2031.

Global Health Sensors Market was valued at US$ 26.0 billion in 2022 and is projected to attain a valuation of US$ 59.4 billion by 2031 at a CAGR of 9.91% during the forecast period 2023-2031.

The Global BCG Tuberculosis Vaccine Market was valued at US$ 63.58 million in 2022 and is expected to attain a market valuation of US$ 91.10 million by 2031, at a CAGR of 4.5% During the Forecast Period 2023-2031.